Sign inJoin waitlistJoin the waitlist

Gene Siegal

FCAP, Executive Vice Chair, UAB Pathology · University of Alabama Hospital

Credentials: · · · ·

History

Executive Vice Chair · University of Alabama Hospital
Present
University of Alabama Hospital
Present
University of Alabama Hospital
Present

Mayo Clinic
1974–1978
University of Louisville School of Medicine
1970–1974

Research

Effect of plasminogen activator (urokinase), plasmin, and thrombin on glycoprotein and collagenous components of basement membrane
Cancer Research · 1981 · 625 citations
Osteosarcoma: the addition of muramyl tripeptide to chemotherapy improves overall survival--a report from the Children's Oncology Group
Journal of Clinical Oncology · 2008 · 560 citations
Osteosarcoma: a randomized, prospective trial of the addition of ifosfamide and/or muramyl tripeptide to cisplatin, doxorubicin, and high-dose methotrexate
Journal of Clinical Oncology · 2005 · 560 citations

David Curiel
84 papers
Shi Wei
65 papers
Ronald Alvarez
51 papers
MB
Mack Barnes
18 papers · 13 as a resident
RL
Robert Lopez
14 papers
KJ
Kenneth Jaffe
13 papers
Frederic Askin
12 papers
LL
Lance Liotta
12 papers
Darshana Jhala
11 papers
DK
David Kaufman
11 papers
NJ
Nirag Jhala
11 papers
Shuko Harada
11 papers · 5 as a fellow

Grants

UAB Core Center for Basic Skeletal Research (CCBSR)
National Institute of Arthritis and Musculoskeletal and Skin Diseases · P30
Project lead · $664.2K · University of Alabama at Birmingham
2007–2011
Armed Replicating Ad for Breast Cancer Bone Metastasis
National Cancer Institute · R01
Contact PI · $225.7K · University of Alabama at Birmingham
2006–2010
Canine Model for Evaluating CRAD Efficacy
National Cancer Institute · R01
Contact PI · $1.1M · University of Alabama at Birmingham
2002–2007
Sfv Mediated Oncogene Knockout for Chemosensitization
National Cancer Institute · R01
Contact PI · $136.7K · University of Alabama at Birmingham
1997–2001